These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21138716)

  • 21. Interactions between specific parameters of cannabis use and verbal memory.
    Wagner D; Becker B; Gouzoulis-Mayfrank E; Daumann J
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):871-6. PubMed ID: 20398718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterizing psychosis-relevant phenomena and cognitive function in a unique population with isolated, chronic and very heavy cannabis exposure.
    D'Souza DC; Ganesh S; Cortes-Briones J; Campbell MH; Emmanuel MK
    Psychol Med; 2020 Oct; 50(14):2452-2459. PubMed ID: 31615592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Self-reports of executive dysfunction in current ecstasy/polydrug Users.
    Hadjiefthyvoulou F; Fisk JE; Montgomery C; Bridges N
    Cogn Behav Neurol; 2012 Sep; 25(3):128-38. PubMed ID: 22960437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive neuropsychological functioning in New Zealand Māori diagnosed with schizophrenia.
    Kake TR; Garrett N; Te Aonui M
    Aust N Z J Psychiatry; 2016 Jun; 50(6):566-76. PubMed ID: 26494850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of chronic ketamine use on frontal and medial temporal cognition.
    Chan KW; Lee TM; Siu AM; Wong DP; Kam CM; Tsang SK; Chan CC
    Addict Behav; 2013 May; 38(5):2128-32. PubMed ID: 23435274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A longitudinal examination of the relationship between cannabis use and cognitive function in mid-life adults.
    McKetin R; Parasu P; Cherbuin N; Eramudugolla R; Anstey KJ
    Drug Alcohol Depend; 2016 Dec; 169():134-140. PubMed ID: 27810656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.
    Indlekofer F; Piechatzek M; Daamen M; Glasmacher C; Lieb R; Pfister H; Tucha O; Lange KW; Wittchen HU; Schütz CG
    J Psychopharmacol; 2009 Jul; 23(5):495-509. PubMed ID: 18635709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined effects of HIV and marijuana use on neurocognitive functioning and immune status.
    Thames AD; Mahmood Z; Burggren AC; Karimian A; Kuhn TP
    AIDS Care; 2016; 28(5):628-32. PubMed ID: 26694807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing cognitive functioning in individuals with cocaine use disorder.
    Frazer KM; Manly JJ; Downey G; Hart CL
    J Clin Exp Neuropsychol; 2018 Aug; 40(6):619-632. PubMed ID: 29226762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Verbal learning and memory in adolescent cannabis users, alcohol users and non-users.
    Solowij N; Jones KA; Rozman ME; Davis SM; Ciarrochi J; Heaven PC; Lubman DI; Yücel M
    Psychopharmacology (Berl); 2011 Jul; 216(1):131-44. PubMed ID: 21328041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropsychological deficits associated with cannabis use in young adults.
    Grant JE; Chamberlain SR; Schreiber L; Odlaug BL
    Drug Alcohol Depend; 2012 Feb; 121(1-2):159-62. PubMed ID: 21920674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Social and psychological factors underlying inhalant abuse.
    Oetting ER; Edwards RW; Beauvais F
    NIDA Res Monogr; 1988; 85():172-203. PubMed ID: 3145437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of 2 Weeks of Monitored Abstinence on Cognition in Adolescent and Young Adult Cannabis Users.
    Wallace AL; Wade NE; Lisdahl KM
    J Int Neuropsychol Soc; 2020 Sep; 26(8):776-784. PubMed ID: 32307027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabis-related deficits in real-world memory.
    Montgomery C; Seddon AL; Fisk JE; Murphy PN; Jansari A
    Hum Psychopharmacol; 2012 Mar; 27(2):217-25. PubMed ID: 22389086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between non-acute adolescent cannabis use and cognition.
    Harvey MA; Sellman JD; Porter RJ; Frampton CM
    Drug Alcohol Rev; 2007 May; 26(3):309-19. PubMed ID: 17454021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropsychological assessment of current and past crack cocaine users.
    De Oliveira LG; Barroso LP; Silveira CM; Sanchez ZV; De Carvalho Ponce J; Vaz LJ; Nappo SA
    Subst Use Misuse; 2009; 44(13):1941-57. PubMed ID: 20001290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropsychological consequences of alcohol and drug abuse on different components of executive functions.
    Fernández-Serrano MJ; Pérez-García M; Schmidt Río-Valle J; Verdejo-García A
    J Psychopharmacol; 2010 Sep; 24(9):1317-32. PubMed ID: 20007413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive impairments in poly-drug ketamine users.
    Liang HJ; Lau CG; Tang A; Chan F; Ungvari GS; Tang WK
    Addict Behav; 2013 Nov; 38(11):2661-6. PubMed ID: 23899429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia.
    Ringen PA; Vaskinn A; Sundet K; Engh JA; Jónsdóttir H; Simonsen C; Friis S; Opjordsmoen S; Melle I; Andreassen OA
    Psychol Med; 2010 Aug; 40(8):1337-47. PubMed ID: 19891810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.